Record PLC (REC)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 48.00 |
|---|---|
| 52-week range | 41.40 – 60.20 |
| Return, 1 month / 3 months | +14.0% / +4.6% |
| Return, 1 year / 3 years | −8.7% / −8.5% |
| Trend | Below its 200-day average |
| RSI (14) | 68 |
| Volatility (1 year) | 35.0% |
| Worst drawdown (1 year) | -26.5% |
| Average daily value traded | 9.10M GBX |
| Dividend yield | 7.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Record plc is a specialist currency and asset management company based in the United Kingdom. It provides currency risk management services, helping institutional clients such as pension funds and corporations manage their exposure to movements between currencies. The firm also offers currency for return strategies and asset management services, and it serves clients in several countries through its offices. Its work centres on advising on and managing currency portfolios rather than on lending or retail banking.
Record PLC trades under the code REC on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Record PLC (REC) trades on the London Exchange in UK. It last closed at GBX 48.00 on 23 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 1,907 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 8.7% and over the last three months it rose 4.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 36 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -1.7% | ||
| From 52-week high | -20.0% | ||
| Momentum | 42 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 4.6% | ||
| 6-month return | -6.5% | ||
| 12-month return, skipping the last month | -19.9% | ||
| Stability (higher is calmer) | 54 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.5% | ||
| Liquidity | 73 · Strong | Trades actively. | |
| Average daily value traded | 9.10M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 87 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 7.5% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +8.6% |
|---|---|
| 1 month | +14.0% |
| 3 months | +4.6% |
| 6 months | −6.5% |
| 1 year | −8.7% |
| 3 years | −8.5% |
| 5 years | −19.9% |
Signals
| 50-day / 200-day average | 43.30 / 48.85 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.78 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Jul 2026 | GBP 0.0145 |
| 20 Nov 2025 | GBP 0.0215 |
| 3 Jul 2025 | GBP 0.0250 |
| 28 Nov 2024 | GBP 0.0215 |
| 11 Jul 2024 | GBP 0.0305 |
| 30 Nov 2023 | GBP 0.0215 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.